Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
Go back to Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals| (NASDAQ: VELO) | Delayed: 11.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.62 | 52 Week High | $ | |||
| Open | $11.62 | 52 Week Low | $ | |||
| Day High | $11.62 | P/E | N/A | |||
| Day Low | $11.62 | EPS | $ | |||
| Volume | 77 | |||||
